Real-world comparison of clopidogrel, prasugrel and ticagrelor in patients undergoing primary percutaneous coronary intervention

Real-world comparison of clopidogrel, prasugrel and ticagrelor in patients undergoing primary percutaneous coronary intervention

Background There is a paucity of real-world outcome data comparing clopidogrel, prasugrel and ticagrelor in primary percutaneous coronary intervention (PPCI) for ST-segment elevation myocardial infarction (STEMI). We sought to assess the association of choice of oral P2Y12-receptor inhibitor with cl...

Full description

Bibliographic Details
Main Authors: Jim McLenachan, Christopher Malkin, Daniel J Blackman, John Greenwood, Stephen Wheatcroft, Paul Baxter, Arvindra Krishnamurthy, Claire Keeble, Michelle Anderson, Kathryn Somers, Natalie Burton-Wood, Charlotte Harland, Jonathan Blaxill
Format: Article
Language:English
Published: BMJ Publishing Group 2019-05-01
Series:Open Heart
Online Access:https://openheart.bmj.com/content/6/1/e000951.full

Internet

https://openheart.bmj.com/content/6/1/e000951.full

Similar Items